The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
May 14th 2024
The FDA has extended the review period for palopegteriparatide in treatment of hyperparathyroidism in adult patients by 3 months to August 14, 2024.
ACE’s and ARBs Not Linked to COVID-19 Mortality But Hypertension Doubles Risk
June 9th 2020Hypertensive patients have a two-fold increased risk of dying from the coronavirus COVID-19 compared to patients without high blood pressure, according to new research published in the European Heart Journal. In addition, if the hypertension is untreated, the risk is greater.
Mortality Estimates in Elderly Atherosclerosis Patients Improved By Knowledge of Exercise Habits
June 9th 2020When asked to elderly patients undergoing coronary artery calcium (CAC) scans, the results of a single question offer providers a better understanding of the individual’s risk of death: "On a scale of 1 - 10, how much do you exercise (0-none, 10-always)?"
Chemical Exposure May Cause Early Menopause
June 3rd 2020Women exposed to Per- and polyfluoroalkyl substance (PFAS), a chemical commonly used in nonstick and waterproof products and firefighting foams, experience menopause earlier according to a study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.